In contrast, we and others demonstrated that T cell activation markers (TAM), notably CD27, but also CD38, Ki-67, CD153, CD161 and HLA-DR, can distinguish active from latent TB, monitor patient response to treatment and retrospectively diagnose TB with unprecedented accuracy10–14. Here, CD38 is linked to tuberculosis.